Stock Price
156.24
Daily Change
-2.79 -1.75%
Monthly
-2.18%
Yearly
101.60%
Q1 Forecast
159.80

Insmed reported $-249.71M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
DBV Technologies USD -34.28M 6.83M Sep/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Heron Therapeutics USD -4.46M 5.76M Sep/2024
Insmed USD -249.71M 11.64M Dec/2025
Novartis USD 4.48B 343M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Ultragenyx Pharmaceutical USD -114M 56.89M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025